Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Yubo International Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$727.99K. For fiscal 2026 it was -$842.80K. The highest annual figure on record is -$22.00K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | -$842.80K | – |
| FY2025 | Dec 31, 2024 | -$1.34M | – |
| FY2024 | Dec 31, 2023 | -$738.97K | – |
| FY2023 | Dec 31, 2022 | -$600.95K | – |
| FY2022 | Dec 31, 2021 | -$1.02M | – |
| FY2020 | Feb 29, 2020 | -$22.00K | – |
| FY2019 | Feb 28, 2019 | -$32.00K | – |
| FY2018 | Feb 28, 2018 | -$55.00K | – |
| FY2017 | Feb 28, 2017 | -$55.00K | – |
| FY2016 | Feb 29, 2016 | -$56.00K | – |
| FY2015 | Feb 28, 2015 | -$63.00K | – |
| FY2014 | Feb 28, 2014 | -$46.00K | – |
| FY2013 | Feb 28, 2013 | -$38.00K | – |
| FY2012 | Feb 29, 2012 | -$43.00K | – |
| FY2011 | Feb 28, 2011 | -$49.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jun 30, 2026 | -$84.10K | – |
| Q1 FY2027CQ1 2026 | Mar 31, 2026 | -$207.16K | – |
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | -$128.75K | – |
| Q3 FY2026CQ3 2025 | Sep 30, 2025 | -$307.98K | -187.2% |
| Q2 FY2026CQ2 2025 | Jun 30, 2025 | -$14.03K | – |
| Q1 FY2026CQ1 2025 | Mar 31, 2025 | -$392.04K | – |
| Q4 FY2025CQ4 2024 | Dec 31, 2024 | -$932.71K | – |
| Q3 FY2025CQ3 2024 | Sep 30, 2024 | $353.32K | +6860.7% |
| Q2 FY2025CQ2 2024 | Jun 30, 2024 | -$427.74K | – |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | -$330.60K | – |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | -$558.35K | – |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | $5.08K | -90.8% |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | -$153.03K | – |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | -$32.67K | -164.1% |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | -$689.53K | – |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | $55.24K | – |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | -$17.63K | -123.1% |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | $50.97K | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | -$63.69K | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | -$30.83K | – |
| Q2 FY2022CQ2 2021 | Jun 30, 2021 | $76.23K | – |
| Q1 FY2022CQ1 2021 | Mar 31, 2021 | -$1.00M | – |
| Q4 FY2020CQ1 2020 | Feb 29, 2020 | -$2.00K | – |
| Q3 FY2020CQ4 2019 | Nov 30, 2019 | -$3.00K | – |
| Q2 FY2020CQ3 2019 | Aug 31, 2019 | -$9.00K | – |
| Q1 FY2020CQ2 2019 | May 31, 2019 | -$8.00K | – |
| Q4 FY2019CQ1 2019 | Feb 28, 2019 | -$8.00K | -900.0% |
| Q3 FY2019CQ4 2018 | Nov 30, 2018 | -$2.00K | – |
| Q2 FY2019CQ3 2018 | Aug 31, 2018 | -$11.00K | – |
| Q1 FY2019CQ2 2018 | May 31, 2018 | -$11.00K | – |
| Q4 FY2018CQ1 2018 | Feb 28, 2018 | $1.00K | – |
| Q3 FY2018CQ4 2017 | Nov 30, 2017 | -$14.00K | – |
| Q2 FY2018CQ3 2017 | Aug 31, 2017 | -$20.00K | – |
| Q1 FY2018CQ2 2017 | May 31, 2017 | -$22.00K | – |
| Q4 FY2017CQ1 2017 | Feb 28, 2017 | -$19.00K | – |
| Q3 FY2017CQ4 2016 | Nov 30, 2016 | -$9.00K | – |
| Q2 FY2017CQ3 2016 | Aug 31, 2016 | -$19.00K | – |
| Q1 FY2017CQ2 2016 | May 31, 2016 | -$8.00K | – |
| Q4 FY2016CQ1 2016 | Feb 29, 2016 | -$8.00K | – |
| Q3 FY2016CQ4 2015 | Nov 30, 2015 | -$8.00K | – |
See a number that looks wrong?